J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.50. The company’s shares closed last Friday at ...

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...

An activity pattern in certain genes responsible for building proteins known as spleen tyrosine kinases can predict which melanoma patients are likely to have severe side effects from ...

GlaxoSmithKline Pharmaceuticals reported a 37.8% year-on-year (YoY) jump in net profit at ₹182.3 crore for the first quarter ...

Adult Vaccine Market Adult Vaccine Market Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Adult Vaccine Market Report, ...

"My life was hell": Man awarded £160,000 damages after Parkinson's drug turned him into gay sex and gambling addict ...

Waterbury Superior Court Judge W. Glen Pierson ruled that defendants, having registered to do business in Connecticut, ...

TD Cowen maintained a Hold rating on GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK), with a consistent price target of $1,790.00. The firm's stance comes after GlaxoSmithKline reported positive Phase ...

GSK turned the mobile phone into a disease detection and risk evaluation tool to raise awareness of under-diagnosed and under-treated chronic obstructive pulmonary disease in China. GSK has always ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.